Close Menu

UT San Antonio

The Center of Excellence in Infection Genomics at UTSA will conduct functional genomics studies of a range of infectious pathogens and seek to develop drugs and vaccines.

The NIH funding will support labs and research cores performing proteomics, systems biology, computational biology, imaging, and other research projects and services.

The deal is the first revenue-generating license for any technology developed at UTSA, and is the first multi-institution license secured through a regional tech-management office created last year to negotiate deals for four UT institutions in south Texas.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.